Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Sectors  >  Healthcare

News : Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors
04/24OXURION : announces full enrollment in Phase 1 trial evaluating the safety of plasma kallikrein inhibitor THR-149 for treatment of DME, ahead of schedule
PU
04/24THERANEXUS : Theranexus announces issuance of chinese patent covering its drug candidate thn102
AN
04/24THERANEXUS : Announces issuance of chinese patent covering its drug candidate thn102
AQ
04/24ONCOPEPTIDES PROVIDES NEW GUIDANCE ON THE PATIENT RECRUITMENT IN THE OCEAN STUDY AND A CLINICAL PROGRAM UPDATE IN A WEBCAST AT 10 : 00 (cet)
AQ
04/24XVIVO PERFUSION : Strong growth in warm perfusion and progress in the r&d portfolio
AQ
04/24Cosmo Pharmaceuticals announces agenda of the R&D Day 2019
TE
04/24PIXIUM VISION : and research partners to report clinical progress with the PRIMA bionic vision system during ARVO 2019 World Conference
GL
04/24MDXHEALTH (R) : MDxHealth provides Q1 2019 business update
AQ
04/24NOVARTIS : starts 2019 with strong sales and double digit core operating income growth, Mayzent launch and Alcon spin-off; profit guidance upgraded
AQ
04/24COSMO PHARMACEUTICALS : announces agenda of the R&D Day 2019
AQ
04/24GETTING MORE FROM LESS : Measuring Cannabis Crop Yield
AQ
04/24ATHENAHEALTH : New layoffs at Athenahealth after company goes private
AQ
04/23ACADIA HEALTHCARE : Oregon complaint, runaways, assaults, parent company's troubles among new Acadia CEO's challenges
AQ
04/23EISAI : Selected as Competitive ICT Strategy Company for 2019
AQ
04/23APHRIA : Announces Closing of US$300 Million 5.25% Convertible Senior Notes Offering and Exercise of US $50 Million Initial Purchasers Option in Full
AQ
Discover
04/24EXTENDICARE : Announces Nomination of Two New Directors and Agreement with Sandpiper Group
AQ
04/24MDXHEALTH (R) : MDxHealth provides Q1 2019 business update
PU
04/24BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
04/24'WE WANT TO BE GOOD NEIGHBOURS : ' Pot plant deals with stink at Edmonton airport
AQ
04/24CATALENT : Invests $14 Million at its Eberbach, Germany Softgel Facility; Expands Production and Packaging Capabilities, and Infrastructure in Response to Increasing Demand for Integrated Turnkey Services
AQ
04/24KYOWA HAKKO KIRIN : Notice Concerning Completion of Consolidated Subsidiary Share Transfer(223KB)
PU
04/24KYOWA HAKKO KIRIN : Submits the Partial Change Approval Application of KHK7580 (evocalcet) in Japan
PU
04/24CLINUVEL PHARMACEUTICALS : Chair Letter to Shareholders
PU
04/24WEEKEND UNLIMITED : Provides Investment Update
AQ
04/24CHEMESIS INTERNATIONAL INC : . Completes Definitive Agreement for Acquisition of Extraction & Manufacturing Facility, & Provides Update on California Operations
AQ
04/24FSD PHARMA : Announces Share Exchange Transaction with Aura Health
AQ
04/24NEXSTIM OYJ : Professor Paul Fitzgerald joins Nexstim's Scientific Advisory Board
GL
04/24CREO MEDICAL : New video abstract featuring Speedboat published
PU
04/24MAXCYTE : Final Results for Year Ended 31 December 2018
PU
04/24SHIELD THERAPEUTICS : Major extension to approval in Switzerland
PU
04/24CELLAVISION AB PRESENTS THE FIRST QUARTER FOR 2019 ON MAY 7 AT 11 : 00 cet
GL
04/24INTRASENSE : Braincarta choose Myrian® to industrialize its application
PU
04/24BTG : Form 8.5 (EPT/RI) - Replacement
PU
04/24DIURNAL : Grant of Orphan Drug Designation in Australia
PU
04/24DIURNAL : Alkindi® granted Orphan Drug Designation in Australia and grant of second Alkindi® patent in Australia
PU
04/24BIOM'UP : granted FDA IDE approval for HEMOSNOW(TM)
AQ
04/24EYECARROT INNOVATIONS : Announces Distribution of Binovi within India as a Feature Product of The Association of Schools and Colleges of Optometry India ASCON 2019 Conference
AQ
04/24BIOM'UP : granted FDA IDE approval for HEMOSNOW(TM)
EQ
04/24PRESCIENT THERAPEUTICS : March 2019 Appendix 4C - Quarterly
PU
04/24XSPRAY PHARMA PUBL : Notice of annual general meeting of Xspray Pharma AB (publ)
AQ
04/24PHARNEXT : Reports Financial Results for Year-End 2018
EQ
04/24PATENT ISSUED FOR SELF-ANCHORING CATHETERS AND METHODS OF USE (USPTO 10,252,034) : PAVmed Inc.
AQ
04/24HORIZON PHARMA PLC TO RELEASE FIRST-QUARTER 2019 FINANCIAL RESULTS AND HOST WEBCAST ON MAY 8, 2019 : Horizon Pharma plc
AQ
04/24STUDY RESULTS FROM BRISTOL-MYERS SQUIBB COMPANY PROVIDE NEW INSIGHTS INTO RHEUMATOID ARTHRITIS (DISCOVERY OF A JAK1/3 INHIBITOR AND USE OF A PRODRUG TO DEMONSTRATE EFFICACY IN A MODEL OF RHEUMATOID ARTHRITIS) : Autoimmune Diseases and Conditions - Rheumatoid Arthritis
AQ
04/24PATENT ISSUED FOR WT1 ANTIGENIC POLYPEPTIDE, AND ANTI-TUMOR AGENT CONTAINING SAID POLYPEPTIDE (USPTO 10,253,075) : Tella Inc.
AQ
04/24NEW MOLECULAR MEDICINE STUDY RESULTS FROM CHUNG ANG UNIVERSITY DESCRIBED (MUCILAGINIBACTER FORMOSUS SP. NOV., A BACTERIUM ISOLATED FROM ROAD-SIDE SOIL) : Health and Medicine - Molecular Medicine
AQ
04/24PATENT APPLICATION TITLED “PHASE-SENSITIVE OPTICAL COHERENCE TOMOGRAPHY TO MEASURE OPTICAL ABERRATIONS IN ANTERIOR SEGMENT” PUBLISHED ONLINE (USPTO 20190099077) : Novartis AG
AQ
04/24FINDINGS FROM ONO PHARMACEUTICAL CO. LTD. IN THE AREA OF BONE RESORPTION REPORTED : Musculoskeletal Diseases and Conditions - Bone Resorption
AQ
04/24QIAGEN'S QUANTIFERON®-TB PASSES MILESTONE OF 60 MILLION TESTS IN GLOBAL FIGHT AGAINST TUBERCULOSIS, CURRENT ANNUAL RUN RATE EXCEEDS 12 MILLION TESTS : Qiagen
AQ
04/24NEW OPHTHALMOLOGY STUDY RESULTS FROM SPARK THERAPEUTICS INC. DESCRIBED (THE NATURAL HISTORY OF INHERITED RETINAL DYSTROPHY DUE TO BIALLELIC MUTATIONS IN THE RPE65 GENE) : Health and Medicine - Ophthalmology
AQ
04/24CONCERT PHARMACEUTICALS ANNOUNCES DECISION FROM PATENT TRIAL AND APPEAL BOARD IN IPR PROCEEDING : Concert Pharmaceuticals Inc.
AQ
04/24RA PHARMACEUTICALS ANNOUNCES COMPLETION OF END-OF-PHASE 2 INTERACTIONS WITH FDA AND DESIGN OF PIVOTAL PHASE 3 GMG STUDY : Ra Pharmaceuticals Inc.
AQ
04/24CENTENE AND WASHINGTON UNIVERSITY COLLABORATE TO ADVANCE PERSONALIZED MEDICINE RESEARCH : Centene Corporation
AQ
04/24“METHOD FOR PREDICTING ONSET OF CEREBRAL INFARCTION, METHOD FOR DETERMINING THERAPEUTIC EFFECT OF ERYTHROPOIETIC FACTOR PREPARATION, AND METHOD FOR DETERMINING STAGE OF CHRONIC KIDNEY DISEASE” IN PATENT APPLICATION APPROVAL PROCESS (USPTO 20190101483) : Sysmex Corporation
AQ
04/24NEW DRUG DEVELOPMENT FINDINGS REPORTED FROM NOVARTIS INSTITUTES OF BIOMEDICAL RESEARCH (EVALUATION OF CAMS FOR C-14 MICROTRACER ADME STUDIES : Opportunities To Change the Current Drug Development Paradigm): Drugs and Therapies - Drug Development
AQ
04/24AURORA CANNABIS PROVIDES CONSTRUCTION UPDATE ON AURORA SUN : Aurora Cannabis Inc.
AQ
04/24INVESTIGATORS FROM MOTIF BIO PLC TARGET BACTERIAL INFECTIONS AND MYCOSES : Bacterial Infections and Mycoses
AQ
04/24PATENT ISSUED FOR METHODS OF MAKING PHARMACEUTICAL COMPOSITIONS WITH ENHANCED STABILITY (USPTO 10,251,956) : Foresee Pharmaceuticals Co. Ltd.
AQ
04/24NEW FINDINGS FROM TAKEDA PHARMACEUTICAL CO. LTD. IN THE AREA OF ANTIEMETIC-ANTIVERTIGO AGENTS DESCRIBED (TAK-071, A MUSCARINIC M-1 RECEPTOR POSITIVE ALLOSTERIC MODULATOR, ATTENUATES SCOPOLAMINE-INDUCED QUANTITATIVE ELECTROENCEPHALOGRAM POWER ...) : Drugs and Therapies - Antiemetic-Antivertigo Agents
AQ
04/24RESEARCHERS FROM SAPIENZA UNIVERSITY OF ROME REPORT RECENT FINDINGS IN HYPERTENSION (MOLECULAR IMPLICATIONS OF NATRIURETIC PEPTIDES IN THE PROTECTION FROM HYPERTENSION AND TARGET ORGAN DAMAGE DEVELOPMENT) : Cardiovascular Diseases and Conditions - Hypertension
AQ
04/24TEVA ANNOUNCES LAUNCH OF A GENERIC VERSION OF ANDROGEL® TESTOSTERONE GEL 1.62% CIII IN THE UNITED STATES : Teva Pharmaceutical Industries Ltd.
AQ
04/24WHY INTERNATIONAL REGULATIONS ON CLINICAL TRIALS CAN ACTUALLY REDUCE COSTS AND SHORTEN TIME TO MARKET : FinancialNewsMedia.com
AQ
04/24PATENT ISSUED FOR SYSTEMS, METHODS, AND DEVICES FOR HIGH-ENERGY IRRADIATION (USPTO 10,252,083) : Varian Medical Systems Inc.
AQ
04/24PATENT APPLICATION TITLED “CONFIGURING A PORTABLE X-RAY DETECTOR FOR USE WITH AN IMAGE ACQUISITION WORKSTATION BASED ON COLOR DETECTION” PUBLISHED ONLINE (USPTO 20190101495) : Varex Imaging Corporation
AQ
04/24PATENT ISSUED FOR SOFT SILICONE MEDICAL DEVICES (USPTO 10,253,112) : Novartis AG
AQ
04/24INVESTIGATORS AT PFIZER INC. DISCUSS FINDINGS IN TYPE 2 DIABETES (LONG-TERM EFFICACY AND SAFETY OF ERTUGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED WITH METFORMIN MONOTHERAPY : 104-week Vertis Met Trial): Nutritional and Metabolic Diseases and Conditions - Type 2 Diabetes
AQ
04/24U.S. CURRENTLY 2ND TO CHINA IN HEMP REVENUES WHICH COULD APPROACH $6 BILLION BY 2020 : FinancialNewsMedia.com
AQ
04/24PATENT ISSUED FOR DAMPING A TELESURGICAL SYSTEM (USPTO 10,251,717) : Intuitive Surgical Operations Inc.
AQ
04/24“ENDOSCOPE APPARATUS AND CAMERA CONTROL UNIT” IN PATENT APPLICATION APPROVAL PROCESS (USPTO 20190102881) : Olympus Corporation
AQ
04/24STUDIES FROM CHUGAI PHARMACEUTICAL CO. LTD. IN THE AREA OF CALCIFIED TISSUE RESEARCH DESCRIBED (SEQUENTIAL TREATMENT WITH ELDECALCITOL AFTER PTH IMPROVES BONE MECHANICAL PROPERTIES OF LUMBAR SPINE AND FEMUR IN AGED OVARIECTOMIZED RATS) : Life Science Research - Calcified Tissue Research
AQ
Prev.5  6  7  8  9   10  11  12  13  14Next
Advertisement